Abstract
Objectives: To determine risk factors for sudden cardiac death and the role of diabetic autonomic neuropathy (DAN) in the Rochester diabetic neuropathy study (RDNS)
Methods: Associations between diabetic and cardiovascular complications, including DAN, and the risk of sudden cardiac death were studied among 462 diabetic patients (151 type 1) enrolled in the RDNS. Medical records, death certificates, and necropsy reports were assessed for causes of sudden cardiac death.
Results: 21 cases of sudden cardiac death were identified over 15 years of follow up. In bivariate analysis of risk covariates, the following were significant: ECG 1 (evolving and previous myocardial infarctions): hazard ratio (HR) = 4.4 (95% confidence interval (CI), 1.6 to 12.1), p = 0.004; ECG 2 (bundle branch block or pacing): HR = 8.6 (2.9 to 25.4), p<0.001; ECG 1 or ECG 2: HR = 4.2 (1.3 to 13.4), p = 0.014; and nephropathy stage: HR = 2.1 (1.3 to 3.4), p = 0.002. Adjusting for ECG 1 or ECG 2, autonomic scores, QTc interval, high density lipoprotein (HDL) cholesterol, 24 hour microalbuminuria, and 24 hour total proteinuria were significant. However, adjusting for nephropathy, none of the autonomic indices, QTc interval, HDL cholesterol, microalbuminuria, or total proteinuria was significant. At necropsy, all patients with sudden cardiac death had coronary artery or myocardial disease.
Conclusions: Sudden cardiac death was correlated with atherosclerotic heart disease and nephropathy, and to a lesser degree with DAN and HDL cholesterol. Although DAN is associated with sudden cardiac death, it is unlikely to be its primary cause.
Full Text
The Full Text of this article is available as a PDF (78.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balkau B., Jouven X., Ducimetière P., Eschwège E. Diabetes as a risk factor for sudden death. Lancet. 1999 Dec 4;354(9194):1968–1969. doi: 10.1016/S0140-6736(99)04383-4. [DOI] [PubMed] [Google Scholar]
- Bellavere F., Ferri M., Guarini L., Bax G., Piccoli A., Cardone C., Fedele D. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J. 1988 Mar;59(3):379–383. doi: 10.1136/hrt.59.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crow Richard S., Hannan Peter J., Folsom Aaron R. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up. Circulation. 2003 Sep 29;108(16):1985–1989. doi: 10.1161/01.CIR.0000095027.28753.9D. [DOI] [PubMed] [Google Scholar]
- Dinneen S. F., Gerstein H. C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997 Jul 14;157(13):1413–1418. [PubMed] [Google Scholar]
- Dyck P. J., Davies J. L., Litchy W. J., O'Brien P. C. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997 Jul;49(1):229–239. doi: 10.1212/wnl.49.1.229. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., Davies J. L., Wilson D. M., Service F. J., Melton L. J., 3rd, O'Brien P. C. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999 Sep;22(9):1479–1486. doi: 10.2337/diacare.22.9.1479. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., Karnes J. L., O'Brien P. C., Litchy W. J., Low P. A., Melton L. J., 3rd The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992 Jun;42(6):1164–1170. doi: 10.1212/wnl.42.6.1164. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., Kratz K. M., Karnes J. L., Litchy W. J., Klein R., Pach J. M., Wilson D. M., O'Brien P. C., Melton L. J., 3rd, Service F. J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817–824. doi: 10.1212/wnl.43.4.817. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., Kratz K. M., Lehman K. A., Karnes J. L., Melton L. J., 3rd, O'Brien P. C., Litchy W. J., Windebank A. J., Smith B. E., Low P. A. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991 Jun;41(6):799–807. doi: 10.1212/wnl.41.6.799. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., Litchy W. J., Lehman K. A., Hokanson J. L., Low P. A., O'Brien P. C. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995 Jun;45(6):1115–1121. doi: 10.1212/wnl.45.6.1115. [DOI] [PubMed] [Google Scholar]
- Dyck P. J., O'Brien P. C., Litchy W. J., Harper C. M., Daube J. R., Dyck P. J. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve. 2001 Mar;24(3):307–310. doi: 10.1002/1097-4598(200103)24:3<307::aid-mus1000>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- Ewing D. J., Boland O., Neilson J. M., Cho C. G., Clarke B. F. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991 Mar;34(3):182–185. doi: 10.1007/BF00418273. [DOI] [PubMed] [Google Scholar]
- Ewing D. J., Campbell I. W., Clarke B. F. Mortality in diabetic autonomic neuropathy. Lancet. 1976 Mar 20;1(7960):601–603. doi: 10.1016/s0140-6736(76)90413-x. [DOI] [PubMed] [Google Scholar]
- Ewing D. J., Campbell I. W., Clarke B. F. The natural history of diabetic autonomic neuropathy. Q J Med. 1980 Winter;49(193):95–108. [PubMed] [Google Scholar]
- Fisher L. D., Lin D. Y. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999;20:145–157. doi: 10.1146/annurev.publhealth.20.1.145. [DOI] [PubMed] [Google Scholar]
- Gerstein H. C., Mann J. F., Yi Q., Zinman B., Dinneen S. F., Hoogwerf B., Hallé J. P., Young J., Rashkow A., Joyce C. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001 Jul 25;286(4):421–426. doi: 10.1001/jama.286.4.421. [DOI] [PubMed] [Google Scholar]
- Harris N. D., Heller S. R. Sudden death in young patients with Type 1 diabetes: a consequence of disease, treatment or both? Diabet Med. 1999 Aug;16(8):623–625. doi: 10.1046/j.1464-5491.1999.00046.x. [DOI] [PubMed] [Google Scholar]
- Jouven X., Desnos M., Guerot C., Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999 Apr 20;99(15):1978–1983. doi: 10.1161/01.cir.99.15.1978. [DOI] [PubMed] [Google Scholar]
- Low P. A. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc. 1993 Aug;68(8):748–752. doi: 10.1016/s0025-6196(12)60631-4. [DOI] [PubMed] [Google Scholar]
- McNally P. G., Lawrence I. G., Panerai R. B., Weston P. J., Thurston H. Sudden death in type 1 diabetes. Diabetes Obes Metab. 1999 May;1(3):151–158. doi: 10.1046/j.1463-1326.1999.00025.x. [DOI] [PubMed] [Google Scholar]
- Mogensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984 Feb 9;310(6):356–360. doi: 10.1056/NEJM198402093100605. [DOI] [PubMed] [Google Scholar]
- Montanez Alicia, Ruskin Jeremy N., Hebert Patricia R., Lamas Gervasio A., Hennekens Charles H. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med. 2004 May 10;164(9):943–948. doi: 10.1001/archinte.164.9.943. [DOI] [PubMed] [Google Scholar]
- Navarro X., Kennedy W. R., Loewenson R. B., Sutherland D. E. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes. 1990 Jul;39(7):802–806. doi: 10.2337/diab.39.7.802. [DOI] [PubMed] [Google Scholar]
- Nkomo V. T., Kottke T. E., Brekke M. J., Brekke L. N., Hammill S. C. The ability of a computer program based on the Marquette Matrix-12 short measurement matrix to replicate coding by the Minnesota ECG coding laboratory. J Electrocardiol. 2000 Oct;33(4):341–348. doi: 10.1054/jelc.2000.18359. [DOI] [PubMed] [Google Scholar]
- O'Brien I. A., McFadden J. P., Corrall R. J. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991 Jun;79(290):495–502. [PubMed] [Google Scholar]
- O'Brien P. C., Dyck P. J. Procedures for setting normal values. Neurology. 1995 Jan;45(1):17–23. doi: 10.1212/wnl.45.1.17. [DOI] [PubMed] [Google Scholar]
- Rathmann W., Ziegler D., Jahnke M., Haastert B., Gries F. A. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med. 1993 Nov;10(9):820–824. doi: 10.1111/j.1464-5491.1993.tb00173.x. [DOI] [PubMed] [Google Scholar]
- Sampson M. J., Wilson S., Karagiannis P., Edmonds M., Watkins P. J. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med. 1990 Jun;75(278):635–646. [PubMed] [Google Scholar]
- Sivieri R., Veglio M., Chinaglia A., Scaglione P., Cavallo-Perin P. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes. Diabet Med. 1993 Dec;10(10):920–924. doi: 10.1111/j.1464-5491.1993.tb00007.x. [DOI] [PubMed] [Google Scholar]
- Stevens M. J., Dayanikli F., Raffel D. M., Allman K. C., Sandford T., Feldman E. L., Wieland D. M., Corbett J., Schwaiger M. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol. 1998 Jun;31(7):1575–1584. doi: 10.1016/s0735-1097(98)00128-4. [DOI] [PubMed] [Google Scholar]
- Stevens M. J., Raffel D. M., Allman K. C., Dayanikli F., Ficaro E., Sandford T., Wieland D. M., Pfeifer M. A., Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998 Sep 8;98(10):961–968. doi: 10.1161/01.cir.98.10.961. [DOI] [PubMed] [Google Scholar]
- Stevens M. J., Raffel D. M., Allman K. C., Schwaiger M., Wieland D. M. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism. 1999 Jan;48(1):92–101. doi: 10.1016/s0026-0495(99)90016-1. [DOI] [PubMed] [Google Scholar]
- Weston P. J., Gill G. V. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The 'dead in bed' syndrome revisited. Diabet Med. 1999 Aug;16(8):626–631. doi: 10.1046/j.1464-5491.1999.00121.x. [DOI] [PubMed] [Google Scholar]
- Ziegler D., Weise F., Langen K. J., Piolot R., Boy C., Hübinger A., Müller-Gärtner H. W., Gries F. A. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia. 1998 Apr;41(4):443–451. doi: 10.1007/s001250050928. [DOI] [PubMed] [Google Scholar]
- Zipes D. P., Wellens H. J. Sudden cardiac death. Circulation. 1998 Nov 24;98(21):2334–2351. doi: 10.1161/01.cir.98.21.2334. [DOI] [PubMed] [Google Scholar]